Immunovant
IMVT
IMVT
168 hedge funds and large institutions have $1.54B invested in Immunovant in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 48 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
13% less funds holding
Funds holding: 192 → 168 (-24)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
48% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 48
Holders
168
Holding in Top 10
4
Calls
$6.75M
Puts
$5.95M
Top Buyers
| 1 | +$38.3M | |
| 2 | +$20.5M | |
| 3 | +$15.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$14.9M |
| 5 |
AC
Armistice Capital
New York
|
+$10.6M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$17.8M | |
| 3 | -$13M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$11.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$10.7M |